Is monoclonality in pituitary adenomas synonymous with neoplasia?

Clinical Endocrinology

Volumn 52, Issue 4, 2000, Pages 393-397

  Levy, Andy ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME 9; CLONE; CUSHING DISEASE; GENE MUTATION; HUMAN; HYPOPHYSIS ADENOMA; METHYLATION; MICROADENOMA; NEOPLASM; ONCOGENE; PRIORITY JOURNAL; PROLACTINOMA; REVIEW; TUMOR SUPPRESSOR GENE; X CHROMOSOME INACTIVATION;

ADENOMA; CLONE CELLS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; HUMANS; HYPERPLASIA; PITUITARY GLAND; PITUITARY NEOPLASMS;

EID: 0034061461     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2000.00955.x     Document Type: Review

References (54)

1. Aihara, T., Noguchi, S., Sasaki, Y. & Imaoka, S. (1996) Does monoclonality mean malignancy. Hepatology, 24, 1550.
2. Alexander, J.M., Biller, B.M.K., Bikkai, H., Zervas, N.T., Arnold, A. & Klibanski, A. (1990) Clinically nonfunctioning pituitary tumors are monoclonal in origin. Journal of Clinical Investigation, 86, 336-340.
3. Asa, S.L., Somers, K. & Ezzat, S. (1998) The MEN-1 gene is rarely down-regulated in pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 83, 3210-3212.
4. Atkinson, A.B., Chestnutt, A., Crothers, E., Woods, R., Weaver, J.A., Kennedy, L. & Sheridan, B. (1985a) Cyclical Cushing's disease: two distinct rhythms in a patient with a basophil adenoma. Journal of Clinical Endocrinology and Metabolism, 60, 328-332.
5. Atkinson, A.B., Kennedy, A.L., Carson, D.J., Hadden, D.R., Weaver, J.A. & Sheridan, B. (1985b) Five cases of cyclical Cushing's syndrome. British Medical Journal, 291, 1453-1457.
6. Bates, A.S., Farrell, W.E., Bicknell, E.J., McNicol, A.M., Talbot, A.J., Broome, J.C., Perrett, C.W., Thakker, R.V. & Clayton, R.N. (1997) Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. Journal of Clinical Endocrinology and Metabolism, 82, 818-824.
7. Biller, B.M.K., Alexander, J.M., Zervas, N.T., Hedley-Whyte, E.T., Arnold, A. & Klibanski, A. (1992) Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease. Journal of Clinical Endocrinology and Metabolism, 75, 1303-1309.
8. Bjerre, P., Lindholm, J. & Videbaek, H. (1986) The spontaneous course of pituitary adenomas and occurrence of an empty sella in untreated acromegaly. Journal of Clinical Endocrinology and Metabolism, 63, 287-291.
9. Bochicchio, D., Losa, M. & Buchfelder, M. (1995) Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group. Journal of Clinical Endocrinology and Metabolism, 80, 3114-3120.
10. Boggild, M.D., Jenkinson, S., Pistorello, M., Boscaro, M., Scanarini, M., McTernan, P., Perrett, C.W., Thakker, R.V. & Clayton, R.N. (1994) Molecular genetic studies of sporadic pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 78, 387-392.
11. Buchfelder, M., Nomikos, P., Schott, W. & Fahlbusch, R. (1999) Persistent suppression of prolactin following surgery and dopamine-agonist treatment in a patient with a large macroprolactinoma. 81st Annual Meeting of the American Endocrine Society, San Diego, pp. 576.
12. Burke, C.W., Adams, C.B., Esiri, M.M., Morris, C. & Bevan, J.S. (1990) Transsphenoidal surgery for Cushing's disease: does what is removed determine the endocrine outcome? Clinical Endocrinology, 33, 525-537.
13. Bystrom, C., Larsson, C., Blomberg, C., Sandelin, K., Falkmer, E., Skogseid, B., Oberg, K., Werner, S. & Nordenskjold, M. (1990) Localization of the MEN 1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proceedings of the National Academy of Sciences of the USA, 87, 1968-1972.
14. Cai, W.Y., Alexander, J.M., Hedley-Whyte, E.T., Scheithauer, B.W., Jameson, J.L., Zervas, N.T. & Klibanski, A. (1994) Ras mutations in human prolactinomas and pituitary carcinomas. Journal of Clinical Endocrinology and Metabolsim, 78, 89-93.
15. Chung, I.M., Schwartz, S.M. & Murry, C.E. (1998) Clonal architecture of normal and atherosclerotic aorta: implications for atherogenesis and vascular development. American Journal of Pathology, 152, 913-923.
16. Clayton, R.N., Boggild, M., Bates, A.S., Bicknell, J., Simpson, D. & Farrell, W. (1997) Tumour suppressor genes in the pathogenesis of human pituitary tumours. Hormone Research, 47, 185-193.
17. Clayton, R.N., Pfeifer, M., Wass, J.A.H., Vanderpump, M., Kyridamou, E., Simpson, D. & Farrell, W.E. (1999) Human pituitary tumours have multiclonal origins. 81st Annual Meeting of the American Endocrine Society, San Diego, pp. 121.
18. Cryns, V.L., Alexander, J.M., Klibanski, A. & Arnold, A. (1993) The retinoblastoma gene in human pituitary tumors. Journal of Clinical Endocrinology and Metabolism, 77, 644-646.
19. Cukiert, A., Buratini, J.A., Liberman, B., Salgado, L.R. & Goldman, J. (1999) Pituitary adenomas and empty sella. 81st Annual Meeting of the American Endocrine Society, San Diego, pp. 1-121.
20. Farrell, W.E., Simpson, D.J., Bicknell, J.E., Talbot, A.J., Bates, A.S. & Clayton, R.N. (1997) Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes. Cancer Research, 57, 2703-2709.
21. Foresti, M., Guidali, A. & Susanna, P. (1991) Primary empty sella. Incidence in 500 asymptomatic subjects examined with magnetic resonance. Radiologica y Medicina Nuclear, 81, 803-807.
22. Gicquel, C., Le Bouc, Y., Luton, J.P., Girard, F. & Bertagna, X. (1992) Monoclonality of corticotroph macroadenomas in Cushing's disease. Journal of Clinical Endocrinology and Metabolism, 75, 472-475.
23. Herman, V., Drazin, N.Z., Gonsky, R. & Melmed, S. (1993) Molecular screening of pituitary adenomas for gene mutations and rearrangements. Journal of Clinical Endocrinology and Metabolism, 77, 50-55.
24. Herman, V., Fagin, J., Gonsky, E., Ezrin, C. & Kovacs, K. (1990) Clonal origins of pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 71, 1427-1433.
25. Herman-Bonert, V. & Fagin, J.A. (1995) Molecular pathogenesis of pituitary tumours. Baillière's Clinical Endocrinology and Metabolism, 9, 203-223.
26. Jeffcoate, W.J., Pound, N., Sturrock, N.D.C. & Lambourne, J. (1996) Long-term follow-up of patients with hyperprolactinaemia. Clinical Endocrinology, 45, 299-303.
27. Kaplan, B., Day, A.L., Quisling, R. & Ballinger, W. (1983) Hemorrhage into pituitary adenomas. Surgical Neurology, 20, 280-287.
28. Karga, H.J., Alexander, J.M., Hedley-Whyte, E.T., Klibanski, A. & Jameson, J.L. (1992) Ras mutations in human pituitary tumors. Journal of Clinical Endocrinology and Metabolism, 74, 914-919.
29. Kruse, A., Klinken, L., Holck, S. & Lindholm, J. (1992) Pituitary histology in Cushing's disease. Clinical Endocrinology, 37, 254-259.
30. Laws, E. Jr, Scheithauer, B.W., Carpenter, S., Randall, R.V. & Abbound, C.F. (1985) The pathogenesis of acromegaly. Clinical and immunocytochemical analysis in 75 patients. Journal of Neurosurgery, 63, 35-38.
31. Levy, A., Hall, L., Yeudall, W.A. & Lightman, S.L. (1994) P53 gene mutations in pituitary adenomas: a rare event. Clinical Endocrinology, 41, 809-814.
32. Levy, A. & Lightman, S.L. (1988) Quantitative in-situ hybridization histochemistry of anterior pituitary hormone mRNA species in human pituitary adenomas. Acta Endocrinologica (Copenhagen), 119, 397-404.
33. Levy, A. & Lightman, S.L. (1992a) Growth hormone-releasing hormone transcripts in human pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 74, 1474-1476.
34. Levy, A. & Lightman, S.L. (1992b) Local production of hypothalamic trophic peptides in human pituitary tumours. Clinical Chemistry Enzymology Communications, 5, 265-273.
35. Levy, A., Powell, M. & Lightman, S.L. (1993) Colocalization of corticotrophin-releasing hormone and oxytocin transcripts in human pituitary adenomas. Endocrine Journal, 1, 117-122.
36. Lissett, C.A., Peacey, S.R., Laing, I., Tetlow, L., Davis, J.R. & Shalet, S.M. (1998) The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma. Clinical Endocrinology, 49, 653-657.
37. Murry, C.E., Gipaya, C.T., Bartosek, T., Benditt, E.P. & Schwartz, S.M. (1997) Monoclonality of smooth muscle cells in human atherosclerosis. Americal Journal of Pathology, 151, 697-705.
38. Nolan, L.A., Lunness, H.R., Lightman, S.L. & Levy, A. (1999) The effects of age and spontaneous adenoma formation on trophic activity in the rat pituitary gland: a comparison with trophic activity in the human pituitary and in human pituitary adenomas. Journal of Neuroendocrinology, 11, 393-401.
39. Pei, L., Melmed, S., Scheithauer, B., Kovacs, K. & Praer, D. (1994) H-ras mutations in human pituitary carcinoma metastases. Journal of Clinical Endocrinology and Metabolism, 78, 842-846.
40. Poncin, J., Stevenaert, A. & Beckers, A. (1999) Somatic MEN1 gene mutation does not contribute significantly to sporadic pituitary tumorigenesis. European Journal of Endocrinology, 140, 573-576.
41. Popovic, V., Micic, D., Nesovic, M., Howlett, T., Doniach, I., Kendereski, A., Djordjevic, P., Manojlovic, D., Micic, H. & Besser, M. (1990) Cushing's disease cycling over ten years. Experimental and Clinical Endocrinology, 92, 143-148.
42. Robinson, D.B. & Michaels, R.D. (1992) Empty sella resulting from the spontaneous resolution of a pituitary macroadenoma. Archives of Internal Medicine, 152, 1920-1923.
43. Satta, M.A., Korbonits, M., Jacobs, R.A., Bolden-Dwinfour, D.A., Kaltsas, G.A., Vangeli, V., Adams, E., Fahlbusch, R. & Grossman, A.B. (1999) Expression of menin gene mRNA in pituitary tumours. European Journal of Endocrinology, 140, 358-361.
44. Schnall, A.M., Kovacs, K., Brodkey, J.S. & Pearson, O.H. (1980) Pituitary Cushing's disease without adenoma. Acta Endocrinology (Copenhagen), 94, 297-303.
45. Schulte, H.M., Oldfield, E.H., Allolio, B., Katz, D.A., Berkman, R.A. & Ali, I.U. (1991) Clonal composition of pituitary adenomas in patients with Cushing's disease: determination by X-chromosome inactivation analysis. Journal of Clinical Endocrinology and Metabolism, 73, 1302-1308.
46. Symon, L. & Mohanty, S. (1982) Haemorrhage in pituitary tumours. Acta Neurochirurgica, 65, 41-49.
47. Tiltman, A.J. (1997) Smooth muscle neoplasms of the uterus. Current Opinion in Obstetrics and Gynecology, 9, 48-51.
48. Tsai, Y.C., Simoneau, A.R., Spruck, C.H.R., Nichols, P.W., Steven, K., Buckley, J.D. & Jones, P.A. (1995) Mosaicism in human epithelium: macroscopic monoclonal patches cover the urothelium. Journal of Urology, 153, 1698-1700.
49. Van Zandijcke, M. & Casselman, J. (1994) The vanishing pituitary adenoma. Acta Neurologica Belgica, 94, 256-258.
50. Vogelstein, G., Fearon, E.R., Hamilton, S.R. & Feinberg, A.P. (1985) Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. Science, 227, 642-645.
51. Wakabayashi, I., Inokuchi, K., Hasegawa, O., Sugihara, H. & Minami, S. (1992) Expression of growth hormone (GH)-releasing factor gene in GH-producing pituitary adenoma. Journal of Clinical Endocrinology and Metabolism, 74, 357-361.
52. Wenbin, C., Asai, A., Teramoto, A., Sanno, N. & Kirino, T. (1999) Mutations of the MEN1 tumor suppressor gene in sporadic pituitary tumors. Cancer Letters, 142, 43-47.
53. Woloschak, M., Roberts, J.L. & Post, K. (1994) c-Myc, c-fos, and c-myb gene expression in human pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 79, 253-257.
54. Zhang, X., Horwitz, G.A., Heaney, A.P., Nakashima, M., Prezant, T.R., Bronstein, M.D. & Melmed, S. (1999) Pituitary tumor transforming gene (PTG) expression in pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 84, 761-767.